The size of the global facial injectable market is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2023 to 2030, according to Grand View Research. As a result, the advent of invasive procedures has spawned “recovery care” as a new niche market within beauty, one that’s ripe for the taking. Several brands have identified this need and are carving out a space to create beauty’s latest category. BY WENDY SY | PUBLISHED MAY 5, 2023

Made for post-injection treatments, recovery care has always been a vital part of the beauty industry, mainly in the form of ice packs and vials of arnica. But when white space emerges, brands come a-running.

According to Grand View Research, the global facial injectable market size was valued at $12.7 billion in 2022. In 2023, it’s projected to exceed $13 billion. And by 2030? Get ready for it — revenue is expected to reach a whopping $27.6 billion. With such high demand, the recovery care category is beauty’s new bright spot of opportunity.